A prodrug nanoparticle approach for the oral delivery of a hydrophilic peptide, leucine(5)-enkephalin, to the brain. (2012)
Attributed to:
Technologies for the Treatment of Brain Diseases
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/mp300009u
PubMed Identifier: 22574705
Publication URI: http://europepmc.org/abstract/MED/22574705
Type: Journal Article/Review
Volume: 9
Parent Publication: Molecular pharmaceutics
Issue: 6
ISSN: 1543-8384